Rajmohan Rajamuthiah
Papers
1
Total Citations
99
H-Index
1
About
Dr. Rajmohan Rajamuthiah is a pioneering researcher in infectious disease drug discovery, specializing in whole-animal screening platforms to combat multidrug-resistant pathogens. His most impactful work centers on developing innovative, automated methodologies using *Caenorhabditis elegans* as a model organism for identifying novel antimicrobials. His landmark 2014 study, cited 99 times, introduced a high-throughput, whole-animal automated platform for drug discovery against methicillin-resistant *Staphylococcus aureus* (MRSA). By leveraging the natural pathogenicity of *S. aureus* in *C. elegans*, Rajamuthiah’s approach bypasses traditional in vitro assays, enabling the identification of compounds that are both efficacious and non-toxic in a living system. This work has significantly advanced the preclinical pipeline for MRSA treatments, addressing a critical global health crisis. His contributions have been instrumental in bridging the gap between basic nematode biology and translational drug development, offering a cost-effective, scalable solution for screening anti-infective agents. Rajamuthiah’s research continues to shape the field of antimicrobial discovery, providing a powerful tool to combat the growing threat of antibiotic resistance.
Research Focus
Key Achievements
Top Papers
- 1